CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,392,674 | -5.8% | 2,086,367 | +8.3% | 0.00% | 0.0% |
| Q2 2023 | $25,891,026 | -15.8% | 1,926,415 | +3.9% | 0.00% | -25.0% |
| Q1 2023 | $30,743,012 | +93631.6% | 1,854,222 | +5.2% | 0.00% | -20.0% |
| Q4 2022 | $32,799 | -99.8% | 1,763,390 | +4.5% | 0.01% | +66.7% |
| Q3 2022 | $21,645,000 | +82.5% | 1,687,121 | -0.3% | 0.00% | +50.0% |
| Q2 2022 | $11,859,000 | -18.4% | 1,691,792 | -3.5% | 0.00% | 0.0% |
| Q1 2022 | $14,540,000 | +24.1% | 1,753,970 | +1.4% | 0.00% | +100.0% |
| Q4 2021 | $11,714,000 | +16.5% | 1,730,313 | -8.8% | 0.00% | 0.0% |
| Q3 2021 | $10,053,000 | -6.2% | 1,896,976 | +1.7% | 0.00% | 0.0% |
| Q2 2021 | $10,721,000 | +31.6% | 1,864,633 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $8,145,000 | +52.2% | 1,766,865 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $5,352,000 | +16.4% | 1,602,694 | +3.5% | 0.00% | 0.0% |
| Q3 2020 | $4,597,000 | -36.8% | 1,548,028 | -1.7% | 0.00% | -50.0% |
| Q2 2020 | $7,273,000 | +22.6% | 1,574,492 | +2.1% | 0.00% | 0.0% |
| Q1 2020 | $5,934,000 | -47.4% | 1,541,357 | -48.8% | 0.00% | +100.0% |
| Q4 2019 | $11,280,000 | +39.5% | 3,008,642 | +97.5% | 0.00% | -50.0% |
| Q3 2019 | $8,088,000 | +50.1% | 1,523,404 | +8.5% | 0.00% | +100.0% |
| Q2 2019 | $5,390,000 | -7.8% | 1,403,791 | +22.4% | 0.00% | -50.0% |
| Q1 2019 | $5,846,000 | +43.1% | 1,146,422 | -46.1% | 0.00% | +100.0% |
| Q4 2018 | $4,084,000 | +12.3% | 2,127,536 | +121.1% | 0.00% | 0.0% |
| Q3 2018 | $3,637,000 | +21.4% | 962,184 | +0.2% | 0.00% | 0.0% |
| Q2 2018 | $2,996,000 | +46.5% | 960,568 | +12.2% | 0.00% | 0.0% |
| Q1 2018 | $2,045,000 | -29.9% | 855,848 | +14.7% | 0.00% | 0.0% |
| Q4 2017 | $2,916,000 | +84.6% | 746,011 | +18.9% | 0.00% | 0.0% |
| Q3 2017 | $1,580,000 | -6.7% | 627,212 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $1,694,000 | +87.8% | 613,849 | +32.7% | 0.00% | – |
| Q1 2017 | $902,000 | +86.4% | 462,677 | +0.3% | 0.00% | – |
| Q4 2016 | $484,000 | -3.4% | 461,231 | +0.2% | 0.00% | – |
| Q3 2016 | $501,000 | +53.7% | 460,267 | +0.1% | 0.00% | – |
| Q2 2016 | $326,000 | -41.9% | 460,026 | -4.2% | 0.00% | – |
| Q1 2016 | $561,000 | -51.8% | 479,987 | +0.9% | 0.00% | -100.0% |
| Q4 2015 | $1,165,000 | -17.4% | 475,673 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $1,410,000 | -16.3% | 470,072 | +15.2% | 0.00% | 0.0% |
| Q2 2015 | $1,684,000 | +10.3% | 407,987 | +15.6% | 0.00% | 0.0% |
| Q1 2015 | $1,527,000 | +93.5% | 352,848 | +32.8% | 0.00% | – |
| Q4 2014 | $789,000 | -15.8% | 265,744 | -5.9% | 0.00% | -100.0% |
| Q3 2014 | $937,000 | +24.8% | 282,334 | -5.0% | 0.00% | – |
| Q2 2014 | $751,000 | +91.6% | 297,260 | +71.0% | 0.00% | – |
| Q1 2014 | $392,000 | +21.7% | 173,788 | +5.1% | 0.00% | – |
| Q4 2013 | $322,000 | -36.2% | 165,418 | 0.0% | 0.00% | – |
| Q3 2013 | $505,000 | +243.5% | 165,418 | 0.0% | 0.00% | – |
| Q2 2013 | $147,000 | – | 165,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |